Fortis Q2 FY26: revenue up 28%, PAT at Rs 125 cr on exceptional gain
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Midcap 150 and 1.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Fortis Healthcare Q2 FY26 standalone: revenue from operations at Rs 455.81 cr, up 27.6% from Rs 357.15 cr YoY. Net profit surged to Rs 125.09 cr from Rs 39.63 cr, aided by exceptional gain of Rs 21.83 cr from reversal of subsidiary investment impairment versus Rs 68.28 cr loss YoY. EBITDA rose to Rs 192.30 cr. EPS stood at Rs 1.65 versus Rs 0.52. H1 FY26 revenue at Rs 888.84 cr.
Strong revenue growth, profit lifted by one-off exceptional gain. Auditor flagged ongoing SFIO probe and Supreme Court matter as emphasis items.